139 related articles for article (PubMed ID: 20732754)
1. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; DeCamp MM
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):353-9. PubMed ID: 20732754
[TBL] [Abstract][Full Text] [Related]
2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
4. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
[TBL] [Abstract][Full Text] [Related]
5. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
7. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
10. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
11. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
13. Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer.
Hotta K; Sekine I; Suzuki K; Kondo H; Asamura H; Sumi M; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N; Tsuchiya R
Thorac Cardiovasc Surg; 2003 Oct; 51(5):283-7. PubMed ID: 14571346
[TBL] [Abstract][Full Text] [Related]
14. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
Cancer; 2010 May; 116(10):2390-400. PubMed ID: 20225332
[TBL] [Abstract][Full Text] [Related]
15. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].
Ji W; Wang LH; Ou GF; Liang J; Feng QF; Xiao ZF; Chen DF; Lü JM; Zhou ZM; Zhang HX; Yin WB
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):783-6. PubMed ID: 19173815
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
18. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of recurrence patterns after curative resection of stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2314-8. PubMed ID: 23158558
[TBL] [Abstract][Full Text] [Related]
20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]